Experts working with you to create, fund, launch, and nuture successful Biotech companies
Our mission is to provide high value strategic analysis to biotechnology companies and their founders, their investors and their leadership. We focus on creating strategies to advance programs, attract funding and drive value for successful corporate development.
We are deeply embedded in academic, bio-pharma and venture capital communities, given us excellent insight into trends across the scientific and investment landscapes. When we partner with biotech we focus on the investable hypothesis: does the science drive a therapeutic rationale that will have a meaningful impact for patients?
If the answer is ‘yes’, that therapeutic will attract investment.
- Novel Immunotherapeutic Approaches to the Treatment of Cancer: Drug Development and Clinical Application (Jun 8, 2016)
- Inaugural International Cancer Immunotherapy Conference: Translating Science into Survival (Sep 9, 2015)
- SugarCone Biotech will be at the International Cancer Immunotherapy Conference: Translating Science into Survival 2015 (Aug 31, 2015)